FDA opens FY2026 veterinary drug research grant applications

FDA’s Center for Veterinary Medicine has opened fiscal year 2026 applications for its Animal and Veterinary Innovation Centers, or AVICs, a grant program meant to build long-term research partnerships with public and private academic institutions. This year’s priorities are aquaculture drug development, drugs for minor ruminant species such as sheep and goats, human food safety requirements for minor species drugs, and antimicrobial use and stewardship. CVM said it may fund up to five grants, with support renewable for as long as four years, and applications are due June 12, 2026. The effort sits within FDA’s broader Animal and Veterinary Innovation Agenda, launched in 2023 to strengthen product development pipelines and modernize veterinary regulatory science. (fda.gov)

Why it matters: For veterinary professionals, especially those in food animal medicine, this is a signal about where FDA wants more evidence and product development help. The priority areas point to persistent gaps in approved therapies for aquaculture and minor species, as well as continued federal focus on antimicrobial stewardship and food safety. AVICs are designed not just to fund basic research, but to generate regulatory science that can help move needed products toward review and approval, which could matter for clinicians, producers, and pet parents alike when treatment options are limited. (fda.gov)

What to watch: FDA will hold a public technical session on May 11, 2026, and the next signal of momentum will be which institutions apply, and whether the agency again turns these grants into multi-year centers with a path toward future product approvals. (fda.gov)